Zilico: Zilico Raises $19M in Total Investments

Zilico, a Manchester, UK-based developer of a cervical cancer diagnostic system, raised a $19m in total funding. The company will receive minimum royalties of $12m and investments totalling $7M. Backers included the MaxHealth Medicine Group (stock code: 836163 (NEEQ) and Deepbridge Capital (UK). Zilico intends to use the funds to continue its global expansion plans [...]